World Drug Report 2006 - United Nations Office on Drugs and Crime

More documents

Recommendations

Info

<strong>World</strong> <strong>Drug</strong> <strong>Report</strong> <strong>2006</strong> Volume 2. Statistics 6.2.2. Primary drugs of abuse among persons treated for drug problems in Asia, 2004 (or latest year available) Distribution of main drug in percentages Amphetamine-type stimulants Country Source Year Opiates Cocaine Amphetamines Ecstasy Cannabis Inhalants Sedatives People treated* Comment Armenia ARQ 2004 100.0% - - - - - - 32 Narcological Clinic inpatients Azerbaijan ARQ / UNODC est. 2003 75.0% - - - 20.0% 5.0% - n.a. Bahrain ARQ 1998 100.0% - - - - - - 1,488 Bangladesh ARQ 2004 90.5% - - - 7.4% - 0.7% 2,587 Dacca, including detoxification centres Brunei Darussalam UNODC FO (DAINAP) 2004 - - 97.4% - 2.5% - - 39 China UNODC FO (DAINAP)/ARQ 2004 98.5% 0.003% 0.05% 0.4% 0.1% - - 105,151 Hongkong, SAR of China Govt/ARQ 2003/4 72.5% - 3.9% - 4.2% - - 13,076 India ARQ 2003/4 49.4% 1.2% 0.2% - 12.5% 0.7% 3.3% 113,000 Medical & non-medical residential treatment centres, compulsory treatment schemes, outpatient treatment program, counselling centres 370 treatment centres & 90 counselling centres including after care and rehab. Indonesia ARQ 2004 92.5% - 3.0% - 1.5% - 2.6% 3,873 <strong>Drug</strong> dependency hospital Iran Govt. 2001 91.6% - - - 2.5% - - 33,990 Israel ARQ 2004 12,000 Japan Govt 2004 0.6% 0.1% 55.8% 0.2% 19.0% 17.9% 4.9% 1,124 Jordan ARQ 1999 21.4% - 45.2% - - 6% - 85 Kazakhstan UNODC FO 2000/04** 74.6% - 0.1% - 20.0% - - 47,903 Kuwait ARQ 2005 56.0% 3.6% 36.0% - 56.0% 2.0% 33.0% 600 Kyrgyzstan ARQ 2004 65.3% - - - 34.7% - - 666 Lao PDR, Vientiane UNODC FO (DAINAP) 2003/04** 5.0% - 77.0% - 2.4% 1,072 Lebanon ARQ / UNODC Est. 2004** 57.0% 4.0% 0.5% 32.0% 6.0% 1,073 3 hospitals and 2 rehabilitation centres Macao, SAR of China ARQ 2004 86.9% - 0.0% 1.4% 2.3% - 0.3% 350 Malaysia ARQ 2003/04** 65.7% - 7.5% 2.3% 23.3% - - 38,672 All voluntary treatment centres, incl. residential treatment Rehab. Centres & addicts under supervision in communities Maldives ARQ 2003 87.0% - - - 13.0% - - 126 Residential and community treatment centre Mongolia ARQ 2001 71.4% - - - 28.6% - - 7 Myanmar UNODC FO (DAINAP)/ ARQ 2004 86.3% - 11.8% - 1.9% - - 1,831 <strong>Drug</strong> treatment centres Nepal, Kathmandu AMCEWG 1994 87.2% - - - 5.4% - - n.a. Oman ARQ 2002 100.0% - - - - - - 7 Pakistan ARQ 2004 49.0% - - - 37.0% - - 4,000 Urban areas Philippines UNODC FO (DAINAP) 2004 0.3% 0.5% 87.1% 0.8% 31.3% - 0.4% 8,189 Qatar ARQ 1997 25.4% - 1.7% - 5.1% 10.2% - 59 Republic of Korea ARQ 2003 1.7% - 57.4% 5.1% 34.1% - 0.6% 176 Saudi Arabia ARQ 2001 15.1% - 41.3% - 15.9% 27.8% - 1,368 Singapore ARQ 2004 100.0% - - - - - - 43 Counselling, detoxification, rehabilitation Syria ARQ 2005 84.2% 0.4% 4.3% 697 Sri Lanka ARQ 2003 100.0% - - - - - - 4,664 Taiwan, Province of China CEWG 2004 93.8% - 21.8% 0.8% 0.4% - 3.5% 12,232 Psychiatric hospitals/clinics Tajikistan ARQ 2004 99.2% - - - - - - 625 Thailand UNODC FO (DAINAP) 2004 14.8% - 58.4% - 9.6% 5.3% - 33,352 <strong>United</strong> Arab Emirates ARQ 2004 92 Uzbekistan ARQ 2003/04** 78.8% - - - 16.8% 0.9% 0.6% 4,761 City and regional drug clinics Viet Nam UNODC FO (DAINAP) 2003/04** 98.0% - 2.0% - - - - 61,775 Average (unweighted) 64.7% 0.3% 16.9% 0.3% 12.2% 2.1% 1.7% 510,800 * Excluding alcohol; please note that treatment definitions differ from country to country This table does not include "other drugs", therefore the percentages will not add up to 100%. ** total number of people treated Sources: UNODC, Annual <strong>Report</strong>s Questionnaire Data; Asian Multicity Epidemiology work group (AMCEWG); Govt. reports 392
6. Consumption 6.2.3. Primary drugs of abuse among persons treated for drug problems in Oceania, 2004 (or latest year available) AmphetamiNe-type stimulants Country* Source Year Opiates Cocaine Cannabis Amphetamines Ecstasy Inhalants Sedatives Australia** Govt 2003/04 31.8% 0.3% 35.2% 17.6% 0.6% - 3.4% 80,831 New Zealand*** Govt 2004 36.7% - 35.8% 20.0% - 3.3% 6,489 Average 34.3% 0.2% 35.5% 18.8% 0.6% - 3.4% 87,320 People treated* * Excluding alcohol; please note that treatment definitions differ from country to country ** Data for Australia refer to closed drug related treatment episodes over the July 2003-June 2004 period. *** The breakdown for New Zealand is based on a telephone sample of drug treatment workers in 2004, excl. replies for alcohol only or mainly alcohol; the total is an estimate previously reported to UNODC. 393
Page 1:
2006 WORLD DRUG RE
Page 4 and 5:
The Office for <st
Page 6 and 7:
Contents Volume I. Analysis Preface
Page 9:
5. PRODUCTION
Page 13 and 14:
3.1. Production: Opium/heroin 3.1.1
Page 15 and 16:
3.1. Production: Opium/heroin Afgha
Page 17 and 18:
3.1. Production: Opium/heroin 215
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
3.1. Production: Opium/heroin Fact
Page 25 and 26:
3.1. Production: Opium/heroin Myanm
Page 27 and 28:
3.1. Production: Opium/heroin Opium
Page 29 and 30:
Page 31 and 32:
3.1. Production: Opium/heroin Lao P
Page 33 and 34:
3.1. Production: Opium/heroin Opium
Page 35 and 36:
3.1. Production: Opium/heroin <stro
Page 37 and 38:
Page 39 and 40:
3.1. Production: Opium/heroin 3.2.
Page 41 and 42:
3.2. Production : Coca/Cocaine 3.2.
Page 43 and 44:
3.2. Production : Coca/Cocaine Colo
Page 45 and 46:
3.2. Production : Coca/Cocaine 243
Page 47 and 48:
3.2. Production : Coca/Cocaine Colo
Page 49 and 50:
3.2. Production : Coca/Cocaine Fact
Page 51 and 52:
3.2. Production : Coca/Cocaine 249
Page 53 and 54:
3.2. Production : Coca/Cocaine Peru
Page 55 and 56:
Page 57 and 58:
3.2. Production : Coca/Cocaine Boli
Page 59 and 60:
3.2. Production : Coca/Cocaine Boli
Page 61 and 62:
Page 63 and 64:
3.3. Production: Cannabis 3.3. Cann
Page 65 and 66:
3.3. Production: Cannabis 263
Page 67 and 68:
3.4.. Production: Amphetamine-type
Page 69 and 70:
3.4.. Production: Amphetamine-type
Page 71 and 72:
3.5. Production: Other Drug
Page 73:
3.5. Production: Other Drug
Page 77 and 78:
4.1. Seizures: Opiates 4.1. Opiates
Page 79 and 80:
4.1. Seizures: Opiates Region/count
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
4.2 Seizures: Cocaine Region/countr
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
4.3. Seizures: Cannabis 4.3. Cannab
Page 113 and 114:
4.3. Seizures: Cannabis Region/coun
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
4.4. Seizures: ATS Region/country o
Page 139 and 140:
Page 141 and 142:
Page 143 and 144: 4.4. Seizures: ATS Region/country o
Page 163: 5. PRICES
Page 166 and 167: World Drug
Page 185 and 186: 6. Consumption 6.1. Consumption: An
Page 187 and 188: 6. Consumption 6.1.2. Cocaine COCAI
Page 189 and 190: 6. Consumption EUROPE CANNABIS Annu
Page 191 and 192: 6. Consumption AMPHETAMINES Annual
Page 193: 6. Consumption 6.2. Treatment deman
Page 197: 6. Consumption 6.2.5. Primary drugs
Page 201 and 202: Methodology Methodology Considerabl
Page 203 and 204: Methodology The use of the concept
Page 205 and 206: Methodology Sources and limitations
Page 207 and 208: Methodology substantially diverging
Page 209 and 210: Methodology can be assumed that the
Page 211 and 212: Methodology country’s participati
Page 213 and 214: Methodology under-estimates are, mo
Page 215 and 216: Methodology Number of countries & t
Page 217 and 218: Methodology population of the count
Page 219 and 220: Printed in Slovakia June 20
show all

World Drug Report 2006 - United Nations Office on Drugs and Crime

Create successful ePaper yourself

Delete template?

Save as template?